Benjamin Kleinstiver, Ph.D.
|
Investigator, Assoc Prof (M) Center for Genomic Medicine, Mass General Research Institute |
|
Associate Professor of Pathology Harvard Medical School |
|
Kayden-Lambert MGH Research Scholar 2023-2028 Mass General Research Institute, Massachusetts General Hospital |
Research Interests
Research Narrative
Genome editing technologies offer hope for the correction of disorders that are the result of mutations in a patient’s DNA. Dr. Kleinstiver's research group pursues protein engineering strategies to improve important properties of CRISPR genome editing enzymes (including their activities, specificities, and targeting ranges, etc.), to develop new genome editing methods, and also explores the feasibility of applying these engineered technologies for the treatment of genetic diseases.
Dr. Kleinstiver is a Principal Investigator in the Center for Genomic Medicine at the Massachusetts General Hospital (MGH) and Harvard Medical School (HMS).
Research in the Kleinstiver laboratory is supported by an NIH DP2 New Innovator Award, as a co-PI/co-I on other NIH awards, an MGH Research Scholar Award, an MGH ECOR Howard M. Goodman Award, CHDI, the Blavatnik Foundation, the Gilbert Foundation, and Angea Biotherapeutics.
Visit the Kleinstiver Lab website at www.kleinstiverlab.org.
| bkleinstiver@mgh.harvard.edu |
| (617) 724-6057 |
|
Center for Genomic Medicine Simches Building 185 Cambridge Street 5th Floor Boston, MA 02114-2790 |